You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Award Disclosure
Dambkowski Carl · SEC Form 4 · Filed Jun 3, 2026
Award
Calculated transaction value
$0
Dambkowski Carl Director
ORKA
Oruka Therapeutics
ORKA
Transaction date
Jun 2, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 1 day later
ORKA daily price context
Close on/before transaction
$55.23
Jun 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 9,136 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0000907654-26-000052
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA Current | Award | Jun 2, 2026 | $0 |